Antiinfectives targeting enzymes and the proton motive force

作者:Feng Xinxin; Zhu Wei; Schurig Briccio Lici A; Lindert Steffen; Shoen Carolyn; Hitchings Reese; Li Jikun; Wang Yang; Baig Noman; Zhou Tianhui; Kim Boo Kyung; Crick Dean C; Cynamon Michael; McCammon J Andrew*; Gennis Robert B; Oldfield Eric
来源:Proceedings of the National Academy of Sciences of the United States of America, 2015, 112(51): E7073-E7082.
DOI:10.1073/pnas.1521988112

摘要

There is a growing need for new antibiotics. Compounds that target the proton motive force (PMF), uncouplers, represent one possible class of compounds that might be developed because they are already used to treat parasitic infections, and there is interest in their use for the treatment of other diseases, such as diabetes. Here, we tested a series of compounds, most with known antiinfective activity, for uncoupler activity. Many cationic amphiphiles tested positive, and some targeted isoprenoid biosynthesis or affected lipid bilayer structure. As an example, we found that clomiphene, a recently discovered undecaprenyl diphosphate synthase inhibitor active against Staphylococcus aureus, is an uncoupler. Using in silico screening, we then found that the anti-glioblastoma multiforme drug lead vacquinol is an inhibitor of Mycobacterium tuberculosis tuberculosinyl adenosine synthase, as well as being an uncoupler. Because vacquinol is also an inhibitor of M. tuberculosis cell growth, we used similarity searches based on the vacquinol structure, finding analogs with potent (similar to 0.5-2 mu g/mL) activity against M. tuberculosis and S. aureus. Our results give a logical explanation of the observation that most new tuberculosis drug leads discovered by phenotypic screens and genome sequencing are highly lipophilic (logP similar to 5.7) bases with membrane targets because such species are expected to partition into hydrophobic membranes, inhibiting membrane proteins, in addition to collapsing the PMF. This multiple targeting is expected to be of importance in overcoming the development of drug resistance because targeting membrane physical properties is expected to be less susceptible to the development of resistance.

  • 出版日期2015-12-22